title: The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
authors: Rebecca S
authors: RS
authors: Bahn
authors: Henry S
authors: HS
authors: Burch
authors: David S
authors: DS
authors: Cooper
authors: Jeffrey R
authors: JR
authors: Garber
authors: Carol M
authors: CM
authors: Greenlee
authors: Irwin L
authors: IL
authors: Klein
authors: Peter
authors: P
authors: Laurberg
authors: I Ross
authors: IR
authors: McDougall
authors: Scott A
authors: SA
authors: Rivkees
authors: Douglas
authors: D
authors: Ross
authors: Julie Ann
authors: JA
authors: Sosa
authors: Marius N
authors: MN
authors: Stan
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced; D008713:Methimazole / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011441:Propylthiouracil / Q000009:adverse effects / Q000627:therapeutic use*; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D013956:Antithyroid Agents; D008713:Methimazole; D011441:Propylthiouracil